Industry Biotech & Health28 JUN 2026

Kite Pharma wins NMPA approval for world's first gastric cancer CAR-T drug

China's NMPA approved Suriqioleucel on June 22, 2026, making it the first CAR-T therapy cleared anywhere in the world for advanced end-stage gastric cancer. Priced at 990,000 RMB per dose, the drug more than doubled median survival in clinical trials, from 3.98 months to 9.17 months.

Subscriber Content

Subscribe to read the full analysis

From $9/month · 7-day free trial

Start Free Trial

Already a subscriber? Log in

Industry Mobility & EV28 June 2026

FAW-Volkswagen launches two PHEV models as joint ventures fall behind

FAW-Volkswagen brought the Magotan PHEV and Tanyue LPHEV to market on June 25, 2026, priced from 169,900 yuan — below the 200,000 yuan threshold that separates the premium family car segment.

Industry Energy & Cleantech28 June 2026

China cements global hydropower lead as Yarlung Tsangpo project targets world record

The International Hydropower Association's latest annual report places China at the top of global hydropower rankings. The Yarlung Tsangpo project, expected to become the world's largest hydropower facility, carries an estimated annual output capability of 300,000 GWh.

Industry Semiconductors28 June 2026

Nvidia procurement team visited Ganzhou three times in 2025 to secure rare earth magnets

A single city in southern China supplies more than 70% of global medium and heavy rare earth output. Nvidia sent buyers there three times in 2025 as early humanoid robot component deliveries began, putting Ganzhou at the centre of a hardware dependency that few outside the industry had mapped.